www.reuters.com Open in urlscan Pro
2600:9000:235a:6400:15:5a3e:9d40:93a1  Public Scan

URL: https://www.reuters.com/business/healthcare-pharmaceuticals/whos-tedros-says-new-covid-variant-concern-could-emerge-2022...
Submission: On December 02 via api from US — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

Skip to main content

Exclusive news, data and analytics for financial market professionalsLearn more
aboutRefinitiv

 * World
   Browse World
    * Africa
    * Americas
    * Asia Pacific
    * China
    * Europe
    * India
    * Israel and Hamas at War
   
    * Japan
    * Middle East
    * Ukraine and Russia at War
    * United Kingdom
    * United States
    * Reuters NEXT

 * US Election
 * Business
   Browse Business
    * Aerospace & Defense
    * Autos & Transportation
    * Davos
    * Energy
    * Environment
    * Finance
    * Healthcare & Pharmaceuticals
   
    * Media & Telecom
    * Retail & Consumer
    * Future of Health
    * Future of Money
    * Take Five
    * World at Work

 * Markets
   Browse Markets
    * Asian Markets
    * Carbon Markets
    * Commodities
    * Currencies
    * Deals
    * Emerging Markets
    * ETFs
    * European Markets
   
    * Funds
    * Global Market Data
    * Rates & Bonds
    * Stocks
    * U.S. Markets
    * Wealth
    * Macro Matters

 * Sustainability
   Browse Sustainability
    * Boards, Policy & Regulation
    * Climate & Energy
    * Land Use & Biodiversity
    * Society & Equity
   
    * Sustainable Finance & Reporting
    * The Switch
    * Reuters Impact
    * COP29

 * Legal
   Browse Legal
    * Government
    * Legal Industry
    * Litigation
    * Transactional
    * US Supreme Court

 * Breakingviews
   Browse Breakingviews
    * Breakingviews Predictions

 * Technology
   Browse Technology
    * Artificial Intelligence
    * Cybersecurity
    * Space
    * Disrupted

 * More
   Investigations
   Sports
    * Athletics
    * Baseball
    * Basketball
    * Cricket
    * Cycling
    * Formula 1
    * Golf
    * NFL
    * NHL
    * Soccer
    * Tennis
   
   Science
   Lifestyle
   Graphics
   Pictures
   Wider Image
   Podcasts
   Fact Check
   Video
   Sponsored Content
    * Reuters Plus
    * Press Releases
   
   Live

My News

Sign InSubscribe



DROP IN COVID ALERTNESS COULD CREATE DEADLY NEW VARIANT, WHO SAYS

By Bhanvi Satija
December 3, 202212:52 AM GMT+1Updated 2 years ago
Text
 * Small Text
 * Medium Text
 * Large Text

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Dec 2 (Reuters) - Lapses in strategies to tackle COVID-19 this year continue to
create the perfect conditions for a deadly new variant to emerge, as parts of
China witness a rise in infections, the head of the World Health Organization
said on Friday.
The comments by WHO Director-General Tedros Adhanom Ghebreyesus mark a change in
tone just months after he said that the world has never been in a better
position to end the pandemic.
Advertisement · Scroll to continue

"We are much closer to being able to say that the emergency phase of the
pandemic is over, but we're not there yet," Tedros said on Friday.
The global health agency estimates that about 90% of the world's population now
has some level of immunity to SARS-COV-2 either due to prior infection or
vaccination.
Item 1 of 2 World Health Organisation Director-General Tedros Adhanom
Ghebreyesus attends a working session on energy and food security during the G20
Summit in Nusa Dua on the Indonesian resort island of Bali on November 15, 2022.
BAY ISMOYO/Pool via REUTERS
[1/2]World Health Organisation Director-General Tedros Adhanom Ghebreyesus
attends a working session on energy and food security during the G20 Summit in
Nusa Dua on the Indonesian resort island of Bali on November 15, 2022. BAY
ISMOYO/Pool via REUTERS Purchase Licensing Rights, opens new tab

"Gaps in testing ... and vaccination are continuing to create the perfect
conditions for a new variant of concern to emerge that could cause significant
mortality," Tedros said.
Advertisement · Scroll to continue

COVID-19 infections are at record highs in China and have started to rise, opens
new tab in parts of Britain after months of decline.
Further easing of COVID-19 testing requirements and quarantine rules in some
Chinese cities was met with a mix of relief and worry on Friday, as hundreds of
millions await an expected shift in national virus policies after widespread
social unrest.
"While COVID-19 and flu can be mild infections for many, we must not forget that
they can cause severe illness or even death for those most vulnerable in our
communities", Mary Ramsay, director of public health programmes at the UK Health
Security Agency, said.

The WHO urged governments globally to focus on reaching those at risk, such as
people over the age of 60 and those with underlying conditions, for vaccination.

Keep up with the latest medical breakthroughs and healthcare trends with the
Reuters Health Rounds newsletter. Sign up here.

Reporting by Bhanvi Satija and Manas Mishra in Bengaluru and Josephine Mason in
London; Editing by Devika Syamnath and Shounak Dasgupta

Our Standards: The Thomson Reuters Trust Principles., opens new tab

 * Suggested Topics:
 * Healthcare & Pharmaceuticals
 * COVID-19
 * Government Health Policy
 * Human Rights

Share
 * X
 * Facebook
 * Linkedin
 * Email
 * Link

Purchase Licensing Rights
Bhanvi Satija

Thomson Reuters

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in
the United States. She has a postgraduate degree in International Journalism
from City, University of London.

 * Email
 * X


READ NEXT

 * Healthcare & PharmaceuticalscategoryArgentina HIV patients, medics fear
   impact of Milei's spending cuts
 * Future of HealthcategoryBritish lawmakers give initial support to assisted
   dying bill
 * New case of mpox variant clade Ib detected in England
 * WorldcategoryNew Zealand suspends poultry exports after first case of H7 bird
   flu
 * LegalcategoryFlavored vape products dispute goes before US Supreme Court
 * SportscategoryWADA investigating the effects of repeated carbon monoxide
   exposure




BUSINESS


 * STELLANTIS FALLS 7% IN PARIS AFTER CEO TAVARES RESIGNS
   
   Boards, Policy & Regulationcategory · December 2, 2024 · 9:08 AM GMT+1 · 8
   min ago
   
   Paris-listed shares in Stellantis STLAM.PA slumped by over 7% on Monday after
   chief executive Carlos Tavares resigned abruptly on Sunday.

 * EnergycategoryAdani Power says no indication of Bangladesh reviewing power
   deal8:50 AM GMT+1 · Updated 25 min ago
 * MarketscategoryMalaysia urges Chinese firms to avoid using it to dodge U.S.
   tariffs8:39 AM GMT+1 · Updated 36 min ago
 * categoryEuro drops 0.50% versus strengthening dollar, France in focus8:32 AM
   GMT+1 · Updated 43 min ago
 * MarketscategoryEuro slides, pressured by French political uncertainty8:30 AM
   GMT+1 · Updated an hour ago




SITE INDEX


LATEST

 * Home
 * Authors
 * Topic Sitemap
 * Archive
 * Article Sitemap


BROWSE

 * World
 * Business
 * Markets
 * Sustainability
 * Legal
 * Breakingviews
 * Technology
 * Investigations
 * Sports
 * Science
 * Lifestyle


MEDIA

 * 
   Videos
 * 
   Pictures
 * 
   Graphics
 * 
   Podcasts


ABOUT REUTERS

 * About Reuters, opens new tab
 * Careers, opens new tab
 * Reuters News Agency, opens new tab
 * Brand Attribution Guidelines, opens new tab
 * Reuters and AI, opens new tab
 * Reuters Leadership, opens new tab
 * Reuters Fact Check
 * Reuters Diversity Report, opens new tab


STAY INFORMED

 * Download the App (iOS), opens new tab
 * Download the App (Android), opens new tab
 * Newsletters


INFORMATION YOU CAN TRUST

Reuters, the news and media division of Thomson Reuters, is the world’s largest
multimedia news provider, reaching billions of people worldwide every day.
Reuters provides business, financial, national and international news to
professionals via desktop terminals, the world's media organizations, industry
events and directly to consumers.


FOLLOW US

 * X
 * Facebook
 * Instagram
 * Youtube
 * Linkedin


THOMSON REUTERS PRODUCTS

 * WESTLAW, OPENS NEW TAB
   
   BUILD THE STRONGEST ARGUMENT RELYING ON AUTHORITATIVE CONTENT,
   ATTORNEY-EDITOR EXPERTISE, AND INDUSTRY DEFINING TECHNOLOGY.

 * ONESOURCE, OPENS NEW TAB
   
   THE MOST COMPREHENSIVE SOLUTION TO MANAGE ALL YOUR COMPLEX AND EVER-EXPANDING
   TAX AND COMPLIANCE NEEDS.

 * CHECKPOINT, OPENS NEW TAB
   
   THE INDUSTRY LEADER FOR ONLINE INFORMATION FOR TAX, ACCOUNTING AND FINANCE
   PROFESSIONALS.


LSEG PRODUCTS

 * WORKSPACE, OPENS NEW TAB
   
   ACCESS UNMATCHED FINANCIAL DATA, NEWS AND CONTENT IN A HIGHLY-CUSTOMISED
   WORKFLOW EXPERIENCE ON DESKTOP, WEB AND MOBILE.

 * DATA CATALOGUE, OPENS NEW TAB
   
   BROWSE AN UNRIVALLED PORTFOLIO OF REAL-TIME AND HISTORICAL MARKET DATA AND
   INSIGHTS FROM WORLDWIDE SOURCES AND EXPERTS.

 * WORLD-CHECK, OPENS NEW TAB
   
   SCREEN FOR HEIGHTENED RISK INDIVIDUAL AND ENTITIES GLOBALLY TO HELP UNCOVER
   HIDDEN RISKS IN BUSINESS RELATIONSHIPS AND HUMAN NETWORKS.

 * Advertise With Us, opens new tab
 * Advertising Guidelines
 * Purchase Licensing Rights, opens new tab

 * Cookies, opens new tab
 * Terms of Use
 * Privacy, opens new tab
 * Digital Accessibility, opens new tab
 * Corrections
 * Site Feedback, opens new tab

All quotes delayed a minimum of 15 minutes. See here for a complete list of
exchanges and delays.

© 2024 Reuters. All rights reserved






WE VALUE YOUR PRIVACY

We and our 152 partners will store and access information on your device with
your consent. Browsing data is collected through the use of cookies to process
personal data. You can give or withdraw your consent by clicking on the `Show
Purposes` button. You can manage your choices and exercise your right to object
on the basis of legitimate interest at any time by clicking on the cog icon at
the bottom left corner of every page.Cookie PolicyPrivacy Statement


HOW AND WHY WE PROCESS PERSONAL DATA

Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised
advertising and content, advertising and content measurement, audience research
and services development. List of Partners (vendors)

Allow All Reject All Show Purposes



Feedback